Make your money go further for just 25p per day

AIM IHT

Coronavirus impact: 20 July - positive news from a respiratory drug

Synairgen

Assessment of Synairgen’s drug in Covid-19 patients could signal a major breakthrough in the treatment patients.


Synairgen: shares soar of positive Covid-19 test results

The share price of Synairgen (LON: SNG), the AIM quoted respiratory drug discovery company, soared over 350% as it announced positive results from its clinical trial of SNG001, its wholly-owned inhaled formulation of interferon beta, in hospitalised Covid-19 patients.

The trial results showed that SNG001 greatly reduced the number of hospitalised Covid-19 patients who progressed from ‘requiring oxygen’ to ‘requiring ventilation’. It also showed that patients who received…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Gamma Communications

Stonking Small Caps: still oozing cash!

21/05/2024 · Company Insights

This fast-growing provider of unified communications is a fantastic company, generating attractive operating margins and heaps…


Whopping dividends from AIM

13/01/2023 · Company Insights

Updates covered here include several AIM and small cap companies offering high dividend payouts. While some…


More on MJ Hudson Group PLC

DUKE of hazard | Bonkers Bargain ahead again

12/12/2022 · Company Insights

Updates from AIM covered here includes news of the suspension of trading in the shares of a…


Coronavirus impact: 20 July - positive news from a respiratory drug

20/07/2020 · Company Insights

Assessment of Synairgen’s drug in Covid-19 patients could signal a major breakthrough in the treatment patients.


More on Pittards

Coronavirus impact: 30 Sept - some big pandemic winners and losers

30/09/2020 · Company Insights

Boohoo Group announced another set of fantastic results and, with a huge pile of cash at…


Coronavirus impact: 20 July - positive news from a respiratory drug

20/07/2020 · Company Insights

Assessment of Synairgen’s drug in Covid-19 patients could signal a major breakthrough in the treatment patients.


More on Synairgen

Not so wacky, but still unusual!

21/10/2021 · Company Insights

A new strategy appears to be delivering for an unusual business covered here. Elsewhere, a small…


Coronavirus impact: 20 July - positive news from a respiratory drug

20/07/2020 · Company Insights

Assessment of Synairgen’s drug in Covid-19 patients could signal a major breakthrough in the treatment patients.


More on Venture Life Group PLC

Knocking the lights out…again

01/02/2022 · Company Insights

One of AIM’s largest companies has issued another positive trading update sending the shares sharply higher…


Acquisition machines ‘mostly’ deliver

02/12/2021 · Company Insights

Results and updates covered here include those of several acquisition driven companies, which also managed to…


More Company Insights

Stonking Small Caps: favourable court ruling lifts shares

22/05/2024 · PCI- PAL PLC

Bonkers Bargain receives an offer | Tough to understand

Bonkers Bargain: results reflect contract delays

21/05/2024 · IXICO PLC

Sign-up to our free email updates

SIGN UP